Navigation Links
Alimera Sciences Reports Second Quarter 2013 Financial Results
Date:8/12/2013

ATLANTA, Aug. 12, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the second quarter ended June 30, 2013.

"We began generating revenue from ILUVIEN in the second quarter of 2013 in Germany and the United Kingdom and continue to make progress in gaining market access in Germany, the United Kingdom and France," said Dan Myers, Alimera's president and chief executive officer. "The initial response has been very positive among early adopting physicians as well as patients, with some of the patients receiving an implant in both eyes."

Market Access Update ILUVIEN was launched commercially in the United Kingdom and Germany in April and May 2013, respectively, and Alimera expects to launch ILUVIEN in France in the first quarter of 2014. In addition to sales activity, Alimera is pursuing expanded reimbursement in the United Kingdom and Germany and will soon be engaged in price negotiations in France.

In the United Kingdom, the recent issuance by the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence (NICE) of a positive Appraisal Consultation Document (ACD) on ILUVIEN is expected to lead to an Appraisal Committee meeting later in August to produce a Final Appraisal Determination (FAD). Alimera is optimistic that a FAD will be issued in September confirming the recommendation of ILUVIEN for the treatment of chronic DME in a pseudophakic population insufficiently responsive to available therapies, however there can be no assurance that NICE will accept the Appraisal Committee's recommendation.

"We are working diligently to increase the availability of ILUVIEN to patients in these countries. While the expanded reimb
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results
2. Alimera Sciences Reports First Quarter 2013 Financial Results
3. Alimera Sciences Secures $20 Million Debt Facility
4. Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results
5. Alimera Sciences Reports Fourth Quarter 2012 Financial Results
6. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
7. Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
8. Alimera Sciences Names European Management Team
9. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
10. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
11. Ohr Pharmaceutical to Present at the Wedbush Life Sciences Management Access Conference on August 14th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 Luoxis Diagnostics, Inc. , ... (NYSE MKT: AMPE), today announced an upcoming presentation ... the American Academy of Surgical Trauma (AAST) and ... Philadelphia, Pennsylvania that will be ... results from a recently completed five-year prospective clinical ...
(Date:8/18/2014)... Mass. and NAGOYA, Japan ... (NYSE: BSX ) and ASAHI INTECC (Securities ... and Nagoya Stock Exchange) have formalized plans to develop ... joint project focuses on creating a device intended to ... The FFR market is an emerging field in interventional ...
(Date:8/18/2014)... , Aug. 18, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01597713/Bioseparation-Systems-for-Global-Biopharmaceutical-Markets.html ... into three types: chromatography, membranes/filters and centrifuges. ... increasing and fueling growth of the global ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4Bioseparation Systems for Global Biopharmaceutical Markets 2Bioseparation Systems for Global Biopharmaceutical Markets 3Bioseparation Systems for Global Biopharmaceutical Markets 4Bioseparation Systems for Global Biopharmaceutical Markets 5Bioseparation Systems for Global Biopharmaceutical Markets 6Bioseparation Systems for Global Biopharmaceutical Markets 7Bioseparation Systems for Global Biopharmaceutical Markets 8Bioseparation Systems for Global Biopharmaceutical Markets 9Bioseparation Systems for Global Biopharmaceutical Markets 10Bioseparation Systems for Global Biopharmaceutical Markets 11Bioseparation Systems for Global Biopharmaceutical Markets 12
... Anthem Blue Cross and Blue Shield in ... transparency initiative beyond major metro areas into the ... and everywhere in between can now access Anthem ... cost information for 59 specific medical procedures performed ...
... 2010 STAAR Surgical Company (Nasdaq: STAA ... invasive ophthalmic products, today reported results for the third ... grew 6% to $13.2 million reflecting core product (IOLs ... decrease in defocused product revenue as compared to the ...
Cached Medicine Technology:Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 2Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 2STAAR Surgical Reports Continued Double Digit Core Revenue Growth 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 4STAAR Surgical Reports Continued Double Digit Core Revenue Growth 5STAAR Surgical Reports Continued Double Digit Core Revenue Growth 6STAAR Surgical Reports Continued Double Digit Core Revenue Growth 7STAAR Surgical Reports Continued Double Digit Core Revenue Growth 8STAAR Surgical Reports Continued Double Digit Core Revenue Growth 9STAAR Surgical Reports Continued Double Digit Core Revenue Growth 10STAAR Surgical Reports Continued Double Digit Core Revenue Growth 11STAAR Surgical Reports Continued Double Digit Core Revenue Growth 12STAAR Surgical Reports Continued Double Digit Core Revenue Growth 13STAAR Surgical Reports Continued Double Digit Core Revenue Growth 14STAAR Surgical Reports Continued Double Digit Core Revenue Growth 15STAAR Surgical Reports Continued Double Digit Core Revenue Growth 16STAAR Surgical Reports Continued Double Digit Core Revenue Growth 17
(Date:8/19/2014)... Kentucky Markey Cancer Center researchers will provide a simple, free ... require testing for a genetic mutation. , Gliomas a ... are the most common and deadly form of brain ... brain cancer cases. In some of these cases, patients have ... mutation and patients who have this tend to survive ...
(Date:8/19/2014)... Hartford/VA Scholars Program has selected three geriatric ... provides career development and mentorship for projects that ... veterans, but for all older adults. , The ... physical activity among veterans, transitions from VA nursing ... disorder in older veterans. The Hartford/VA Geriatric Scholars ...
(Date:8/19/2014)... 2014 United Benefit Advisors (UBA), ... is pleased to announce Sihle Insurance Group as ... provides a single solution for insurance, financial services, ... needs. With a focus on commercial and personal ... insurance solutions, and payroll services, they are able ...
(Date:8/19/2014)... Utah (PRWEB) August 19, 2014 ... Solution, published a new guide on compliance and ... Benefits, small businesses want to offer employee health ... insurance is unsustainable. Additionally, there are new advantages ... guaranteed-issue, and lower costs. , The new ...
(Date:8/19/2014)... Respected Dallas Plastic Surgeon ... nationwide to feature one of the most advanced ... UltraShape. UltraShape uses ultrasound waves to selectively breakdown ... , The UltraShape System, by Syneron Medical, is ... targets subcutaneous fat, while keeping the surrounding skin ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors Welcomes New Partner Firm Sihle Insurance Group 2Health News:United Benefit Advisors Welcomes New Partner Firm Sihle Insurance Group 3Health News:Dallas Plastic Surgeon Dr. Benjamin Bassichis is Among the First to Offer UltraShape for Non-Surgical Liposuction 2Health News:Dallas Plastic Surgeon Dr. Benjamin Bassichis is Among the First to Offer UltraShape for Non-Surgical Liposuction 3
... ... QT Beat-to-Beat(sm) Studies , ... Rochester, N.Y. (PRWEB) March 11, 2010 -- iCardiac Technologies, Inc., a leader in ... pharmaceutical company has awarded iCardiac a comprehensive cardiac safety study. iCardiac will provide ...
... ... last three years fundraising to send life-saving bed nets to families in ... grassroots campaign to prevent malaria in Africa, the leading killer of children ... and plans to raise $50,000 by the time he starts college. This ...
... ... Plunge, a benefit for the Special Olympics. , ... Salt Lake City, UT (PRWEB) March 11, 2010 -- Bullfrog International, makers ... Pelican Bay Marina in Saratoga Springs, Utah and hosted by the Saratoga Police Department. Bullfrog ...
... ... from a national workshop have been released to address deep-vein thrombosis (DVT) and pulmonary ... each year. , ... Washington, D.C. (PRWEB) March 11, 2010 -- Three critical recommendations from a national workshop ...
... , WEDNESDAY, March 10 (HealthDay News) -- By analyzing ... U.S. scientists have identified gene mutations associated with the ... the limbs, hands and feet. , The study, published ... of Medicine , involved sequencing the complete genome of ...
... infestations, study shows, , WEDNESDAY, March 10 (HealthDay News)-- ... ivermectin is more effective than the standard treatment, the ... published in the March 11 issue of the ... percent of those treated with ivermectin were lice-free after ...
Cached Medicine News:Health News:Top 10 Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2Health News:High School Student's College Prerequisite: Save Five Thousand Lives in Africa. Teen Supports Nothing But Nets in Malaria Fight 2Health News:High School Student's College Prerequisite: Save Five Thousand Lives in Africa. Teen Supports Nothing But Nets in Malaria Fight 3Health News:Hot Tub Company Helps Swimmers Thaw and Supports Special Olympics 2Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 2Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 3Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 4Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 5Health News:Gene Mutations Identified for Charcot-Marie-Tooth Syndrome 2Health News:For Tough Head Lice, Pill Tops Lotion 2Health News:For Tough Head Lice, Pill Tops Lotion 3
... The Awaya stereo test was developed to ... Awaya Stereo test employs the more reliable ... eye. It is not dependent on polarizing spectacles ... first target is an attractive image of a ...
... is designed to assist patients with red-green color ... filter cuts off wavelengths shorter than 582 nm ... of their most difficult color distinctions. A color ... determine whether a color is in the longer ...
Features a twist-on backswitch, with a diffused, cobalt blue light beam....
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra...
Medicine Products: